ASHEVILLE, N.C. and ATLANTA, July 11, 2012 /PRNewswire/ -- Genova Diagnostics, Inc. and Metametrix, Inc., leading clinical laboratories in applying a systems-based testing approach to the diagnosis, treatment and prevention of complex chronic disease, today announced they have combined efforts under one company.
"We share a mission of improving the health of patients worldwide by striving to be the best provider of comprehensive and innovative clinical laboratory services. I look forward to offering my continued support in achieving our shared goals," said J. Alexander Bralley, PhD, CEO of Metametrix. Bralley will continue working in a consulting capacity in the newly aligned organization, focusing on development of next-generation testing approaches and clinical education programs.
The combined entity will provide a broader range of testing services, as well as increase the breadth of support and resources dedicated to physicians and their patients. "Consolidating our companies significantly increases our global presence. Together, we serve over 9,000 healthcare practitioners annually throughout the United States and internationally in 45 countries with our 400 employees and three locations in Asheville, North Carolina, Duluth, Georgia, and London, England. Our combined resources will allow us to expand investments in research & development, clinical trials, medical education and market expansion," said Ted Hull, Chairman and CEO of Genova Diagnostics.
Genova Diagnostics, Inc., which purchased all assets of Metametrix, Inc., will continue to operate under both brands at this time. Financial terms of the transaction were not disclosed.
Established in 1984, Metametrix is a pioneer in producing cutting-edge technology for the measurement of nutritional insufficiencies, metabolic dysfunction, microbial imbalances and toxic influences on health. Metametrix is committed to applying the latest adva
|SOURCE Metametrix, Inc.|
Copyright©2012 PR Newswire.
All rights reserved